Cyriac Roeding
Earli
Cyriac Roeding is a Silicon Valley-based German-American entrepreneur and angel investor. He serves as the Co-founder and CEO of Earli, an early cancer detection and treatment firm headquartered in South San Francisco. Earli is based on Synthetic Biopsy technology from Stanford University and is funded by leading venture captial firms including Andreessen Horowitz and Khosla Ventures.
Videos
A New Frontier in Cancer Treatment
In his visionary DLD25 talk, Earli CEO Cyriac Roeding presents a revolutionary approach to cancer diagnosis and treatment, which leverages synthetic biology to turn cancer cells against themselves. “Who of you has had…
Video details
A Push for Europe
How can Europe leverage its strength in science and research to become a global innovation leader? This DLD25 panel discussion, moderated by Stefan Drüssler (UnternehmerTUM), offers a range of different perspectives from EU…
Video detailsArticles
The Promptah No. 3: “Future Positive!”
In its third issue, DLD’s people magazine for curious minds highlights the rapid evolution of AI and celebrates Esther Dyson as a pioneer of using tech for good.
Article details
Turning Cancer Against Itself
Californian startup Earli aims to outsmart one of the world’s deadliest diseases by combining biology, engineering and software. CEO Cyriac Roeding shares details with DLD.
Article detailsEvents
DLD Munich 2025
Europe’s leading innovation conference celebrates its 20th anniversary from January 16-18, 2025, in Munich. Find out about speakers, location details and how to attend…
Event details